We are leveraging evidence and influencing the national dialogue about value.

25-26 of 26 Publications

Journal of Public Economics 2009

Innovation and the welfare effects of public drug insurance

Prescription drug insurance is able to lower static deadweight loss without reducing incentives for innovation, with the result that the public provision of drug insurance can be welfare-improving, even for risk-neutral and purely self-interested consumers. 


Health Affairs 2008

Drug Licenses: A New Model For Pharmaceutical Pricing

A drug-licensing model for health care is proposed which has the promise of increasing drug use without altering patients' out-of-pocket spending, health plans' costs, or drug companies' profits. In such a model, people would purchase annual drug licences that would guarantee unfettered access to a clinically optimal number of prescriptions over the course of a year.